Business Description
InnoCan Pharma Corp
NAICS : 325412
SIC : 3741
ISIN : CA45783P1027
Share Class Description:
XCNQ:INNO: Ordinary SharesCompare
Compare
Traded in other countries / regions
INNO.CanadaIP4.GermanyINNPF.USA IPO Date
2019-09-24Description
InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 115.82 | |||||
| Equity-to-Asset | 0.59 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 9.83 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 35.4 | |||||
| 3-Year EPS without NRI Growth Rate | 15.1 | |||||
| 3-Year FCF Growth Rate | 10.2 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 72.08 | |||||
| 9-Day RSI | 66.89 | |||||
| 14-Day RSI | 61.78 | |||||
| 6-1 Month Momentum % | -11.76 | |||||
| 12-1 Month Momentum % | 20 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.68 | |||||
| Quick Ratio | 1.99 | |||||
| Cash Ratio | 1.53 | |||||
| Days Inventory | 317.02 | |||||
| Days Sales Outstanding | 0.45 | |||||
| Days Payable | 44.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -12.5 | |||||
| Shareholder Yield % | -2.35 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 87.73 | |||||
| Operating Margin % | -27.99 | |||||
| Net Margin % | -34.6 | |||||
| FCF Margin % | -29.01 | |||||
| ROE % | -93.09 | |||||
| ROA % | -71.15 | |||||
| ROIC % | -201.56 | |||||
| ROC (Joel Greenblatt) % | -570.01 | |||||
| ROCE % | -79.03 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.51 | |||||
| PB Ratio | 15.24 | |||||
| Price-to-Tangible-Book | 16 | |||||
| EV-to-EBIT | -15.5 | |||||
| EV-to-EBITDA | -15.62 | |||||
| EV-to-Revenue | 4.6 | |||||
| EV-to-FCF | -15.86 | |||||
| Price-to-Net-Current-Asset-Value | 16 | |||||
| Price-to-Net-Cash | 32 | |||||
| Earnings Yield (Greenblatt) % | -6.45 | |||||
| FCF Yield % | -5.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
InnoCan Pharma Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 18.371 | ||
| EPS (TTM) (C$) | -0.023 | ||
| Beta | 0.03 | ||
| Volatility % | 69.15 | ||
| 14-Day RSI | 61.78 | ||
| 14-Day ATR (C$) | 0.016229 | ||
| 20-Day SMA (C$) | 0.28475 | ||
| 12-1 Month Momentum % | 20 | ||
| 52-Week Range (C$) | 0.18 - 0.52 | ||
| Shares Outstanding (Mil) | 280.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
InnoCan Pharma Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
InnoCan Pharma Corp Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
InnoCan Pharma Corp Frequently Asked Questions
What is InnoCan Pharma Corp(XCNQ:INNO)'s stock price today?
The current price of XCNQ:INNO is C$0.32. The 52 week high of XCNQ:INNO is C$0.52 and 52 week low is C$0.18.
When is next earnings date of InnoCan Pharma Corp(XCNQ:INNO)?
The next earnings date of InnoCan Pharma Corp(XCNQ:INNO) is .
Does InnoCan Pharma Corp(XCNQ:INNO) pay dividends? If so, how much?
InnoCan Pharma Corp(XCNQ:INNO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers